Tags

Type your tag names separated by a space and hit enter

Women's interest in vaginal microbicides.
Fam Plann Perspect. 1999 Jan-Feb; 31(1):16-23.FP

Abstract

CONTEXT

Each year, an estimated 15 million new cases of sexually transmitted diseases (STDs), including HIV, occur in the United States. Women are not only at a disadvantage because of their biological and social susceptibility, but also because of the methods that are available for prevention.

METHODS

A nationally representative sample of 1,000 women aged 18-44 in the continental United States who had had sex with a man in the last 12 months were interviewed by telephone. Analyses identified levels and predictors of women's worry about STDs and interest in vaginal microbicides, as well as their preferences regarding method characteristics. Numbers of potential U.S. microbicide users were estimated.

RESULTS

An estimated 21.3 million U.S. women have some potential current interest in using a microbicidal product. Depending upon product specifications and cost, as many as 6.0 million women who are worried about getting an STD would be very interested in current use of a microbicide. These women are most likely to be unmarried and not cohabiting, of low income and less education, and black or Hispanic. They also are more likely to have visited a doctor for STD symptoms or to have reduced their sexual activity because of STDs, to have a partner who had had other partners in the past year, to have no steady partner or to have ever used condoms for STD prevention.

CONCLUSIONS

A significant minority of women in the United States are worried about STDs and think they would use vaginal microbicides. The development, testing and marketing of such products should be expedited.

Links

FREE Publisher Full Text

Authors+Show Affiliations

Darroch JE
Alan Guttmacher Institute (AGI), New York, USA.
Frost JJ
No affiliation info available

MeSH

Administration, IntravaginalAdultAnti-Infective Agents, LocalAttitude to HealthConflict, PsychologicalConsumer BehaviorContraception BehaviorFamily CharacteristicsFemaleHIV InfectionsHealth BehaviorHealth Care SurveysHumansLogistic ModelsMotivationMultivariate AnalysisOdds RatioSampling StudiesSexual BehaviorSexually Transmitted DiseasesSocioeconomic FactorsUnited StatesWomen's Health

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

10029928

Citation

Darroch, J E., and J J. Frost. "Women's Interest in Vaginal Microbicides." Family Planning Perspectives, vol. 31, no. 1, 1999, pp. 16-23.
Darroch JE, Frost JJ. Women's interest in vaginal microbicides. Fam Plann Perspect. 1999;31(1):16-23.
Darroch, J. E., & Frost, J. J. (1999). Women's interest in vaginal microbicides. Family Planning Perspectives, 31(1), 16-23.
Darroch JE, Frost JJ. Women's Interest in Vaginal Microbicides. Fam Plann Perspect. 1999 Jan-Feb;31(1):16-23. PubMed PMID: 10029928.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Women's interest in vaginal microbicides. AU - Darroch,J E, AU - Frost,J J, PY - 1999/2/25/pubmed PY - 1999/2/25/medline PY - 1999/2/25/entrez KW - Americas KW - Contraception KW - Contraceptive Methods KW - Contraceptive Usage KW - Developed Countries KW - Diseases KW - Economic Factors KW - Family Planning KW - Hiv Infections--prevention and control KW - Infections KW - Method Acceptability--women KW - North America KW - Northern America KW - Reproductive Tract Infections KW - Research And Development KW - Research Methodology KW - Research Report KW - Sampling Studies KW - Sexually Transmitted Diseases--prevention and control KW - Sexually Transmitted Diseases--women KW - Studies KW - Surveys KW - Technology KW - United States KW - Vaginal Spermicides KW - Viral Diseases KW - Women SP - 16 EP - 23 JF - Family planning perspectives JO - Fam Plann Perspect VL - 31 IS - 1 N2 - CONTEXT: Each year, an estimated 15 million new cases of sexually transmitted diseases (STDs), including HIV, occur in the United States. Women are not only at a disadvantage because of their biological and social susceptibility, but also because of the methods that are available for prevention. METHODS: A nationally representative sample of 1,000 women aged 18-44 in the continental United States who had had sex with a man in the last 12 months were interviewed by telephone. Analyses identified levels and predictors of women's worry about STDs and interest in vaginal microbicides, as well as their preferences regarding method characteristics. Numbers of potential U.S. microbicide users were estimated. RESULTS: An estimated 21.3 million U.S. women have some potential current interest in using a microbicidal product. Depending upon product specifications and cost, as many as 6.0 million women who are worried about getting an STD would be very interested in current use of a microbicide. These women are most likely to be unmarried and not cohabiting, of low income and less education, and black or Hispanic. They also are more likely to have visited a doctor for STD symptoms or to have reduced their sexual activity because of STDs, to have a partner who had had other partners in the past year, to have no steady partner or to have ever used condoms for STD prevention. CONCLUSIONS: A significant minority of women in the United States are worried about STDs and think they would use vaginal microbicides. The development, testing and marketing of such products should be expedited. SN - 0014-7354 UR - https://www.unboundmedicine.com/medline/citation/10029928/Women's_interest_in_vaginal_microbicides_ L2 - https://www.guttmacher.org/pubs/journals/3101699.html DB - PRIME DP - Unbound Medicine ER -